Marsella, Rosanna
Ahrens, K.
Sanford, R.
Trujillo, A.
Massre, D.
Soeberdt, M.
Abels, C.
Funding for this research was provided by:
Wolff
Article History
Received: 15 November 2018
Revised: 26 April 2019
Accepted: 15 June 2019
First Online: 24 August 2019
Compliance with ethical standards
:
: Dr. Marsella has received Grants from Novartis, Pfizer, Zoetis, Boehringer, Merial, Bioresponse and Artic. Dr. Marsella does not own stock in any of these companies. Dr. Abels and Dr. Soeberdt are employees of Dr. August Wolff GmbH & Co. KG Arzneimittel. Dr. Abels and Dr. Soeberdt are named as inventor on a patent application claiming novel 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.